Condition

Psychoses

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 17 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials17
Recruiting0
Common interventions16
Lead sponsors shown14
Advertisement

Clinical trials

17 shown
Adapting a Socio-cognitive Intervention to Early Psychosis ServicesNCT07102784 · 2025-08-25
NOT_YET_RECRUITING
Epileptic Psychoses and Their Link With Ictal Emotions and ConsciousnessNCT06960811 · 2025-05-02
COMPLETED
Patient-controlled Admissions in Inpatient Mental Health ServicesNCT03609515 · 2011-04-01
COMPLETED
Duration of Untreated Psychosis (DUP) and Pathways to Care in NordlandNCT01196858 · 2010-09-01
COMPLETED
D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic SchizophreniaNCT00960219 · 2009-04-01
COMPLETED
DNA Diagnostics for Minimizing Metabolic Side-Effects of AntipsychoticsNCT00752960 · 2007-01-01
UNKNOWN
Sarcosine Preventive Therapy for Individuals At High Risk for SchizophreniaNCT00276263 · 2006-08-01
WITHDRAWN
Pharmacy Interventions to Improve Chronic Disease Medication RefillNCT00469365 · 2006-01-01
COMPLETED
Sarcosine or D-Serine Add-on Treatment for Chronic SchizophreniaNCT00491569 · 2005-01-01
COMPLETED
Sarcosine (N-Methylglycine) Monotherapy for SchizophreniaNCT00328276 · 2004-12-01
COMPLETED
Access, Detection and Psychological TreatmentsNCT00260273 · 2004-08-01
UNKNOWN
Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational DrugNCT00087542 · 2004-03-01
COMPLETED
Aripiprazole in Patients With Psychosis Associated With Parkinson's DiseaseNCT00095810 · 2003-07-01
COMPLETED
Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode SchizophreniaNCT00159120 · 2001-11-01
COMPLETED
Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode SchizophreniaNCT00159133 · 2001-11-01
COMPLETED
Early Pharmacological and Psychological Intervention for Late Prodromal States of PsychosisNCT00204061 · 2001-01-01
COMPLETED
Brain Cell Injury in Patients With A First Episode of PsychosisNCT00070889 · 1999-09-01
COMPLETED

Common interventions

Leading sponsors

Trial status mix

COMPLETED13
UNKNOWN2
NOT_YET_RECRUITING1
WITHDRAWN1

Phase mix

PHASE25
PHASE44
NA2
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.